Abstract: The present invention relates to mast cell cultures that are derived from hematopoietic progenitors and the use thereof. The invention describes a method for generating in-vitro cultures of human mast cells with functional phenotype of connective tissue-type mast cells. By monitoring the levels of chemokines released into the medium, such mast cell cultures can be used as a cell-based assay to assess regulation of mast cell functions and pharmacological activities of tryptase inhibitors.
Type:
Grant
Filed:
April 3, 2014
Date of Patent:
July 19, 2016
Assignee:
Apollonian Biosystems Limited
Inventors:
See-Ying Tam, Yee San Issan Tam, Hang Yung Alaster Lau
Abstract: The present invention relates to mast cell cultures that are derived from hematopoietic progenitors and the use thereof. The invention describes a method for generating in-vitro cultures of human mast cells with functional phenotype of connective tissue-type mast cells. By monitoring the levels of chemokines released into the medium, such mast cell cultures can be used as a cell-based assay to assess regulation of mast cell functions and pharmacological activities of tryptase inhibitors.
Type:
Application
Filed:
April 3, 2014
Publication date:
July 31, 2014
Applicant:
Apollonian Biosystems Limited
Inventors:
See-Ying TAM, Yee San Issan TAM, Hang Yung Alaster LAU